Evidence has suggested EGCG significantly reduces the expression of VEGF that directly acts on VEGFR on vascular endothelial cells and subsequently leads to the angiogenic dysregulation in HCC (Shirakami et al., 2009; Sabry et al., 2019). The gene discussed is KDR; the disease is hepatocellular carcinoma.